Radient Pharmaceuticals Corporation (RXPC) issued corporate report today, July 13th, 2011. It highlights investment catalysts in 5 key areas of Radient’s business. These catalysts include the Company’s:
•Recent Focus on IVD Business
•Multiple Revenue Stream Opportunities
•Building Marketing & Distribution Channels for Approved Indications
•Plan To Introduce IVDs for New Indications in US In Conjunction with CLIA Certified Labs
•Intellectual Property Portfolio
As of 1:30 p.m. RXPC security has been traded over 5M shares.
Radient Pharmaceuticals Issues Corporate Report
TUSTIN, CA–(Marketwire – 07/13/11) – Radient Pharmaceuticals Corporation “the Company” or “Radient” (OTCQX: RXPC) (Pinksheets:RXPC), a developer and marketer of In Vitro Diagnostic (IVD) cancer tests, announced today it has issued a Corporate Report. This 12-page document provides an overview of Radient’s business, its products, its markets, its strategy, and its finances. Investors or interested parties may view and download the report at the Company’s website. […]
Radient Pharmaceuticals Corporation (RXPC)
2492 Walnut Avenue
Suite 100
Tustin, CA 92780-6953
United States
Phone: 714-505-4461
Fax: 714-505-4464
http://www.radient-pharma.com
Radient Pharmaceuticals Corporation, a pharmaceutical company, engages in the research, development, manufacture, and marketing of diagnostic and skin care products. It offers ONKO-SURE, a proprietary in-vitro diagnostic cancer test, which is used for the detection and/or monitoring of lung, breast, stomach, liver, colon, rectal, ovarian, esophageal, cervical, trophoblastic, thyroid, malignant lymphoma, and pancreatic cancers.
The company also has interests in the Combined Immunogene Therapy, a cancer vaccine therapy technology, which is used to build the body’s immune system and destroy cancer cells. In addition, it provides Elleuxe brand of anti-aging skin care products, including hydrating firming cream, renergie hydrating cleanser, intense hydrating cleanser, visable renewing hydrating softener, and smoothing renewing eye moisturizer. The company sells its products through distributors to hospitals, clinical laboratories, clinics, and other health care organizations primarily in the United States, Canada, Chile, Europe, India, Korea, Taiwan, and Vietnam.
